Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial
Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page
- Check3 days agoChange DetectedFooter revision label updated from v3.6.0 to v3.6.2, signaling a new build of the page. The change does not affect the displayed study details or navigation.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe listing now displays 'No longer looking for participants', signaling that enrollment has ended; additional help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to guide users.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, representing a small maintenance update without visible content changes.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision label v3.5.4 was added, replacing the previous v3.5.3 to denote a minor build/version update for the page. This reflects maintenance or a status update rather than changes to study information or outcomes.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, signaling an updated version of the page documentation. Aside from this metadata update, the page content and structure appear unchanged.SummaryDifference0.1%

- Check75 days agoChange DetectedFooter shows site revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.